153 related articles for article (PubMed ID: 8737779)
1. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.
Bujía J; Kim C; Ostos P; Sudhoff H; Kastenbauer E; Hültner L
Eur Arch Otorhinolaryngol; 1996; 253(4-5):252-5. PubMed ID: 8737779
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.
Bujía J; Kim C; Ostos P; Kastenbauer E; Hültner L
Eur Arch Otorhinolaryngol; 1996; 253(3):152-7. PubMed ID: 8652157
[TBL] [Abstract][Full Text] [Related]
3. [A quantitative study of the presence of interleukin-1 and interleukin-6 in cholesteatoma of the middle ear].
Aumente PO; Bujía J; Kim C; Jiménez Giménez J; López Villarejo P
Acta Otorrinolaringol Esp; 1996; 47(4):259-62. PubMed ID: 8962724
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
5. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Schmidt M; Grünsfelder P; Hoppe F
Eur Arch Otorhinolaryngol; 2001 Nov; 258(9):472-6. PubMed ID: 11769995
[TBL] [Abstract][Full Text] [Related]
7. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
8. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
[TBL] [Abstract][Full Text] [Related]
9. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
Bujia J; Kim C; Ostos-Aumente P; Lopez-Villarejo J; Kastenbauer E
Eur Arch Otorhinolaryngol; 1997; 254(1):6-8. PubMed ID: 9115708
[TBL] [Abstract][Full Text] [Related]
10. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
Schilling V; Bujia J; Negri B; Kastenbauer E
Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
[TBL] [Abstract][Full Text] [Related]
11. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
12. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
Chung JW; Yoon TH
Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
14. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
15. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
Kinoshita K
Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
[TBL] [Abstract][Full Text] [Related]
16. Expression of RANKL and proliferation abilities of cultured human middle ear cholesteatoma epithelial cells.
Miyasato M; Takeno S; Hirakawa K
Hiroshima J Med Sci; 2013 Mar; 62(1):1-6. PubMed ID: 23600327
[TBL] [Abstract][Full Text] [Related]
17. [Autocrine growth mechanisms of cholesteatoma epithelium].
Schilling V; Holly A; Bujía J; Schulz P
Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
[TBL] [Abstract][Full Text] [Related]
18. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
Akimoto R; Pawankar R; Yagi T; Baba S
ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
[TBL] [Abstract][Full Text] [Related]
19. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
